Topics › Drug Policy › Ibogaine
Policy Brief by Gregory Ferenstein
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Gregory Ferenstein
Commentary by Gregory Ferenstein and Geoffrey Lawrence
Testimony by Geoffrey Lawrence